Inovio Pharmaceuticals, Inc.
INO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45,497 | -$23,519,412 | -$19,695 | -$19,382 |
| Dep. & Amort. | $750 | $741,670 | $743 | $776 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $757 | $834,792 | $1,399 | $1,316 |
| Change in WC | -$730 | $94 | -$4,774 | -$731 |
| Other Non-Cash | $23,147 | $1,131,497 | -$4,548 | -$1,643 |
| Operating Cash Flow | -$21,573 | -$20,811,359 | -$26,874 | -$19,664 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$68 | -$31 | -$59 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$4,946,073 | $0 | $0 |
| Inv. Sales/Matur. | $8,935 | $10,966,571 | $8 | $34,585 |
| Other Inv. Act. | $0 | -$738,401 | $0 | $59 |
| Investing Cash Flow | $8,867 | $5,282,066 | -$52 | $34,644 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,185 | $0 | $1,102 | $13,082 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $17,737 | -$34,777 | -$74 | $16,064 |
| Financing Cash Flow | $24,922 | -$34,777 | $1,028 | $29,145 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $12,216 | -$15,564,070 | -$25,898 | $44,126 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24,351 | $39,915,447 | $65,813 | $21,687 |
| End Cash | $36,567 | $24,351,377 | $39,915 | $65,813 |
| Free Cash Flow | -$21,641 | -$20,811,359 | -$26,933 | -$19,664 |